154 related articles for article (PubMed ID: 29508747)
1. Cancer control in war-torn Iraq.
Alwan N; Kerr D
Lancet Oncol; 2018 Mar; 19(3):291-292. PubMed ID: 29508747
[No Abstract] [Full Text] [Related]
2. UK Government urged to recognise post-COVID-19 cancer backlog.
Wilkinson E
Lancet Oncol; 2021 Jul; 22(7):910. PubMed ID: 34090554
[No Abstract] [Full Text] [Related]
3. How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?
Schleicher SM; Wood NM; Lee S; Feeley TW
Oncology (Williston Park); 2016 May; 30(5):468-74. PubMed ID: 27188679
[No Abstract] [Full Text] [Related]
4. [Foreword].
Wörmann B
Onkologie; 2012; 35 Suppl 5():2. PubMed ID: 22965287
[No Abstract] [Full Text] [Related]
5. Developing cancer care institutions for the developing world.
Pereira I; Katz MS; Simcock R
Lancet Oncol; 2018 Nov; 19(11):1436. PubMed ID: 30507476
[No Abstract] [Full Text] [Related]
6. Developing an independent Palestinian cancer care capacity.
Gil Z; Atrash F; Za'aroura S; Billan S; Nammour W
Lancet Oncol; 2019 Nov; 20(11):1485-1486. PubMed ID: 31674309
[No Abstract] [Full Text] [Related]
7. Cancer control reform in Nigeria.
Fatokun O
Lancet Oncol; 2017 Jan; 18(1):19-20. PubMed ID: 28049569
[No Abstract] [Full Text] [Related]
8. Going Beyond Being Lost in Transition: A Decade of Progress in Cancer Survivorship.
Nekhlyudov L; Ganz PA; Arora NK; Rowland JH
J Clin Oncol; 2017 Jun; 35(18):1978-1981. PubMed ID: 28437163
[No Abstract] [Full Text] [Related]
9. National cancer control plans: a global analysis.
Romero Y; Trapani D; Johnson S; Tittenbrun Z; Given L; Hohman K; Stevens L; Torode JS; Boniol M; Ilbawi AM
Lancet Oncol; 2018 Oct; 19(10):e546-e555. PubMed ID: 30268693
[TBL] [Abstract][Full Text] [Related]
10. A legacy of war: cancer care fragmentation in Iraq.
Balakrishnan VS
Lancet Oncol; 2023 Sep; 24(9):959. PubMed ID: 37573862
[No Abstract] [Full Text] [Related]
11. Survivorship 2.0.
Grunfeld E
J Clin Oncol; 2019 Dec; 37(34):3179-3182. PubMed ID: 31180817
[No Abstract] [Full Text] [Related]
12. The war on cancer: progress at what price?
Konski A
J Clin Oncol; 2011 Apr; 29(12):1503-4. PubMed ID: 21402613
[No Abstract] [Full Text] [Related]
13. Moonshot or groundshot: addressing Europe's cancer challenge through a patient-focused, data-enabled lens.
Lawler M; Naredi P; Cufer T; Banks I; Lievens Y; Vassal G; Aapro M; Sotlar MJ; Philip T; Jassem J; Pelouchova J; Meunier F; Sullivan R;
Lancet Oncol; 2019 Nov; 20(11):1482-1485. PubMed ID: 31674308
[No Abstract] [Full Text] [Related]
14. Funding Cancer Quality Improvement: Payer's Perspective.
Schumacher H
J Oncol Pract; 2015 May; 11(3):180-1. PubMed ID: 25804984
[No Abstract] [Full Text] [Related]
15. [Looking to the future].
Hübner J; Kappauf HW
Onkologie; 2012; 35 Suppl 5():26-8. PubMed ID: 22965291
[No Abstract] [Full Text] [Related]
16. Cancer in Botswana: resources and opportunities.
Suneja G; Ramogola-Masire D; Medhin HG; Dryden-Peterson S; Bekelman JE
Lancet Oncol; 2013 Jul; 14(8):e290-1. PubMed ID: 23816293
[No Abstract] [Full Text] [Related]
17. Increasing access to next-generation sequencing in oncology for Brazil.
Santos M; Coudry RA; Ferreira CG; Stefani S; Cunha IW; Zalis MG; Araujo LH
Lancet Oncol; 2019 Jan; 20(1):20-23. PubMed ID: 30614460
[No Abstract] [Full Text] [Related]
18. Key factors impacting the delivery and financing of oncology care in the United States.
Goldsmith PJ; Paivanas T
J Natl Compr Canc Netw; 2006 May; 4(5):434-7. PubMed ID: 16715607
[No Abstract] [Full Text] [Related]
19. US Cancer Care System Ill-Equipped to Deliver New Advances to Patients.
Rappaport M
J Oncol Pract; 2016 May; 12(5):397. PubMed ID: 27170686
[No Abstract] [Full Text] [Related]
20. Can we afford the war on cancer?
Szucs TD
Onkologie; 2008 Mar; 31(3):81. PubMed ID: 18322408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
